Rita J. Balice-Gordon insider trades: Collegium Pharmaceutical (COLL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rita reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | COLL | ↓ Sell | 3,650 | $47.03 | $172K | Direct | Dec 9, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other COLL insiders
Open-market trades in the last 12 months
About Rita J. Balice-Gordon's insider trades
Rita J. Balice-Gordon is an insider at Collegium Pharmaceutical (COLL). Since Dec 5, 2025, Rita has reported no open-market purchases and 1 sale worth $172K on SEC Form 4. In the last 12 months: 1 sale ($172K).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COLL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.